BioSpace News Archive

Deals

Johnson & Johnson Completes Acquisition of Proteologix, Inc.

Acquisition includes two pre-clinical bispecific antibodies targeting proven disease pathways, offering the potential to transform the treatment paradigm for patients living with atopic dermatitis and other immune-mediated diseases.

June 21, 2024
·
6 min read
Biotech Bay

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.

June 21, 2024
·
3 min read
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies

June 21, 2024
·
4 min read
Press Releases

Genome Editing Market Size to Reach USD 40.48 Billion by 2033

June 21, 2024
·
1 min read
BioForest

Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases

Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.

June 21, 2024
·
3 min read
Drug Development

Mozart Therapeutics Announces Oral Presentation on MTX-101 at the 2024 American Diabetes Association’s 84th Scientific Sessions

Mozart Therapeutics, a clinical stage biopharmaceutical company focused on the development of CD8 Treg modulators for the treatment of autoimmune diseases, today presented new preclinical data on the Company’s lead program, MTX-101.

June 21, 2024
·
2 min read
BioMidwest

Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients

Findings from the Lowering Events in Non-proliferative retinopathy in Scotland Trial revealed that fenofibrate, a medication used for many years to reduce blood fat levels, significantly reduces the progression of diabetic retinopathy, a diabetes-related eye disease.

June 21, 2024
·
4 min read
Business

On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, welcomes Dr. Yona Geffen, as a consultant, to support the Company’s preclinical and clinical activities.

June 21, 2024
·
6 min read
Business

Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences

Palisade Bio, Inc. today provided an update on key areas of progress for its previously announced strategic collaboration with Strand Life Sciences (“Strand”), a leading bioinformatics specialist, aimed at advancing precision medicine for ulcerative colitis (UC) therapy.

June 21, 2024
·
4 min read
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), announced today that its board of directors have approved a private placement of up to 697,350 units

June 21, 2024
·
3 min read